Related Experiment Video
Updated: Aug 14, 2026
07:02
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
[DNA microarrays and papillary thyroid carcinoma gene expression profile]
Barbara Jarzab1, Elzbieta Gubała, Dariusz Lange
1Department of Nuclear Medicine and Endocrine Oncology, Maria Skłodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch.
Endokrynologia Polska
|December 15, 2005
Summary
This study compares high-density oligonucleotide and cDNA microarray technologies for gene expression profiling. Papillary thyroid carcinoma analysis using DNA microarrays is also presented.
Area of Science:
- Molecular Biology
- Genomics
- Bioinformatics
Context:
- DNA microarrays are crucial for gene expression profiling.
- Two primary platforms exist: high-density oligonucleotide and cDNA microarrays.
- Understanding their comparative performance is essential for accurate analysis.
Purpose:
- To compare the technological platforms of high-density oligonucleotide and cDNA microarrays for gene expression analysis.
- To present recent findings on papillary thyroid carcinoma (PTC) using DNA microarray technology.
Summary:
- The study details a comparative analysis of high-density oligonucleotide microarrays and cDNA microarrays.
- Gene expression profiles were analyzed using both platforms.
- Results from DNA microarray analysis of papillary thyroid carcinoma are discussed.
Impact:
- Provides insights into the strengths and limitations of different microarray technologies.
- Aids researchers in selecting the optimal platform for gene expression studies.
- Contributes to the understanding of papillary thyroid carcinoma pathogenesis through gene expression data.
